Total Valuation
Veri Medtech Holdings has a market cap or net worth of $46.93M. The enterprise value is $35.97M.
Market Cap$46.93M
Enterprise Value$35.97M
Share Statistics
Veri Medtech Holdings has 20,000,004 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding20,000,004
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Veri Medtech Holdings’s return on equity (ROE) is 0.99 and return on invested capital (ROIC) is 123.26%.
Return on Equity (ROE)0.99
Return on Assets (ROA)-12.63
Return on Invested Capital (ROIC)123.26%
Return on Capital Employed (ROCE)0.96
Revenue Per Employee433.93K
Profits Per Employee-93.42K
Employee Count25
Asset Turnover58.68
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Veri Medtech Holdings is ―. Veri Medtech Holdings’s PEG ratio is 0.00.
PE Ratio―
PS Ratio2.30
PB Ratio-10.57
Price to Fair Value-10.57
Price to FCF78.94
Price to Operating Cash Flow203.91
PEG Ratio0.00
Income Statement
In the last 12 months, Veri Medtech Holdings had revenue of 10.85M and earned -2.34M in profits. Earnings per share was -0.12.
Revenue10.85M
Gross Profit8.17M
Operating Income-2.27M
Pretax Income-2.34M
Net Income-2.34M
EBITDA-2.15M
Earnings Per Share (EPS)-0.12
Cash Flow
In the last 12 months, operating cash flow was 230.14K and capital expenditures 7.00, giving a free cash flow of 230.15K billion.
Operating Cash Flow230.14K
Free Cash Flow230.15K
Free Cash Flow per Share0.01
Dividends & Yields
Veri Medtech Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.16
52-Week Price Change486.50%
50-Day Moving Average1.58
200-Day Moving Average1.37
Relative Strength Index (RSI)62.12
Average Volume (3m)335.00
Important Dates
Veri Medtech Holdings upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Veri Medtech Holdings as a current ratio of 0.05, with Debt / Equity ratio of -15.45%
Current Ratio0.05
Quick Ratio0.05
Debt to Market Cap0.02
Net Debt to EBITDA-0.22
Interest Coverage Ratio-33.28
Taxes
In the past 12 months, Veri Medtech Holdings has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Veri Medtech Holdings EV to EBITDA ratio is -11.82, with an EV/FCF ratio of 80.45.
EV to Sales2.34
EV to EBITDA-11.82
EV to Free Cash Flow80.45
EV to Operating Cash Flow79.66
Balance Sheet
Veri Medtech Holdings has $6.15K in cash and marketable securities with $422.14K in debt, giving a net cash position of -$415.99K billion.
Cash & Marketable Securities$6.15K
Total Debt$422.14K
Net Cash-$415.99K
Net Cash Per Share-$0.02
Tangible Book Value Per Share-$0.12
Margins
Gross margin is 68.93%, with operating margin of -20.89%, and net profit margin of -21.53%.
Gross Margin68.93%
Operating Margin-20.89%
Pretax Margin-21.53%
Net Profit Margin-21.53%
EBITDA Margin-19.84%
EBIT Margin-20.89%
Analyst Forecast
The average price target for Veri Medtech Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast46.53%
EPS Growth Forecast-237.01%